Tarsus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TARS for the last quarter is 48.12 M USD, and it's 17.90% higher compared to the previous quarter. The net income of Q3 24 is -23.42 M USD.